167 related articles for article (PubMed ID: 36530191)
1. Effect of Osteoblast-Specific Deletion of the Proton Receptor OGR1.
Krieger NS; Chen L; Becker J; Chan M; Bushinsky DA
JBMR Plus; 2022 Dec; 6(12):e10691. PubMed ID: 36530191
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the proton receptor OGR1 in mouse osteoclasts impairs metabolic acidosis-induced bone resorption.
Krieger NS; Chen L; Becker J; Chan MR; Bushinsky DA
Kidney Int; 2021 Mar; 99(3):609-619. PubMed ID: 33159961
[TBL] [Abstract][Full Text] [Related]
3. Increased bone density in mice lacking the proton receptor OGR1.
Krieger NS; Yao Z; Kyker-Snowman K; Kim MH; Boyce BF; Bushinsky DA
Kidney Int; 2016 Mar; 89(3):565-73. PubMed ID: 26880453
[TBL] [Abstract][Full Text] [Related]
4. Metabolic acidosis regulates RGS16 and G protein signaling in osteoblasts.
Krieger NS; Bushinsky DA
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F424-F430. PubMed ID: 34396788
[TBL] [Abstract][Full Text] [Related]
5. Metabolic acidosis increases intracellular calcium in bone cells through activation of the proton receptor OGR1.
Frick KK; Krieger NS; Nehrke K; Bushinsky DA
J Bone Miner Res; 2009 Feb; 24(2):305-13. PubMed ID: 18847331
[TBL] [Abstract][Full Text] [Related]
6. Effect of metabolic and respiratory acidosis on intracellular calcium in osteoblasts.
Frick KK; Bushinsky DA
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F418-25. PubMed ID: 20504884
[TBL] [Abstract][Full Text] [Related]
7. The proton-activated ovarian cancer G protein-coupled receptor 1 (OGR1) is responsible for renal calcium loss during acidosis.
Imenez Silva PH; Katamesh-Benabbas C; Chan K; Pastor Arroyo EM; Knöpfel T; Bettoni C; Ludwig MG; Gasser JA; Brandao-Burch A; Arnett TR; Bonny O; Seuwen K; Wagner CA
Kidney Int; 2020 May; 97(5):920-933. PubMed ID: 32173037
[TBL] [Abstract][Full Text] [Related]
8. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of fibroblast growth factor 23 by metabolic acidosis requires osteoblastic intracellular calcium signaling and prostaglandin synthesis.
Krieger NS; Bushinsky DA
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F882-F886. PubMed ID: 28298360
[TBL] [Abstract][Full Text] [Related]
10. Role of proton receptor OGR1 in bone response to metabolic acidosis?
Jorgetti V; Drüeke TB; Ott SM
Kidney Int; 2016 Mar; 89(3):529-31. PubMed ID: 26880446
[TBL] [Abstract][Full Text] [Related]
11. Hymenialdisine: A Marine Natural Product That Acts on Both Osteoblasts and Osteoclasts and Prevents Estrogen-Dependent Bone Loss in Mice.
Wang Q; Chen D; Jin H; Ye Z; Wang C; Chen K; Kuek V; Xu K; Qiu H; Chen P; Song D; Zhao J; Liu Q; Davis RA; Song F; Xu J
J Bone Miner Res; 2020 Aug; 35(8):1582-1596. PubMed ID: 32286705
[TBL] [Abstract][Full Text] [Related]
12. Tuning the resorption-formation balance in an
Remmers SJA; van der Heijden FC; de Wildt BWM; Ito K; Hofmann S
Bone Rep; 2023 Jun; 18():101646. PubMed ID: 36578830
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of intracellular calcium release blocks acid-induced bone resorption.
Krieger NS; Bushinsky DA
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F91-7. PubMed ID: 21048027
[TBL] [Abstract][Full Text] [Related]
14. Disruption of Kif3a in osteoblasts results in defective bone formation and osteopenia.
Qiu N; Xiao Z; Cao L; Buechel MM; David V; Roan E; Quarles LD
J Cell Sci; 2012 Apr; 125(Pt 8):1945-57. PubMed ID: 22357948
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function.
Hodge JM; Wang Y; Berk M; Collier FM; Fernandes TJ; Constable MJ; Pasco JA; Dodd S; Nicholson GC; Kennedy RL; Williams LJ
Biol Psychiatry; 2013 Jul; 74(1):32-9. PubMed ID: 23260229
[TBL] [Abstract][Full Text] [Related]
17. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.
Xia WF; Jung JU; Shun C; Xiong S; Xiong L; Shi XM; Mei L; Xiong WC
J Bone Miner Res; 2013 Oct; 28(10):2122-35. PubMed ID: 23649480
[TBL] [Abstract][Full Text] [Related]
18. Autophagy in osteoblasts is involved in mineralization and bone homeostasis.
Nollet M; Santucci-Darmanin S; Breuil V; Al-Sahlanee R; Cros C; Topi M; Momier D; Samson M; Pagnotta S; Cailleteau L; Battaglia S; Farlay D; Dacquin R; Barois N; Jurdic P; Boivin G; Heymann D; Lafont F; Lu SS; Dempster DW; Carle GF; Pierrefite-Carle V
Autophagy; 2014; 10(11):1965-77. PubMed ID: 25484092
[TBL] [Abstract][Full Text] [Related]
19. Not etched in bone: the role of osteoclast proton-sensing receptors.
Ott SM
Kidney Int; 2021 Mar; 99(3):542-545. PubMed ID: 33637200
[TBL] [Abstract][Full Text] [Related]
20. The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo.
Mori T; Horibe K; Koide M; Uehara S; Yamamoto Y; Kato S; Yasuda H; Takahashi N; Udagawa N; Nakamichi Y
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32987399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
